PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22694351-3	2012	Because metformin, an AMPK activator that is a favored first-line therapeutic option for type 2 diabetes, may confer benefits in chronic inflammatory diseases and cancers independent of its ability to normalize blood glucose, there is now considerable interest in identifying and exploiting AMPK"s anti-inflammatory effects.	Metformin	8-17	protein kinase AMP-activated catalytic subunit alpha 2	Homo sapiens	22-26	
22694351-3	2012	Because metformin, an AMPK activator that is a favored first-line therapeutic option for type 2 diabetes, may confer benefits in chronic inflammatory diseases and cancers independent of its ability to normalize blood glucose, there is now considerable interest in identifying and exploiting AMPK"s anti-inflammatory effects.	Metformin	8-17	protein kinase AMP-activated catalytic subunit alpha 2	Homo sapiens	291-295